线粒体动力学在血液癌症发展和进展中的作用
Saurav Doshi1,2,3,4, Christina Glytsou1,2,3,4,5
1Graduate Program in Pharmaceutical Sciences, School of Graduate Studies, Rutgers University, Piscataway, 08854 NJ USA.
Current pharmacology reports
|October 28, 2025
概括
血液癌细胞操纵线粒体动力学以促进生长和药物耐药性. 针对这些过程提供了新的治疗策略和血液恶性瘤的预测生物标志物.
科学领域:
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体动力学,包括融合和裂变,对于细胞平衡至关重要.
- 线粒体动态的失调与各种慢性疾病有关.
- 癌细胞,特别是血液癌症,利用线粒体重塑来维持生存和进展.
研究的目的:
- 审查线粒体动力学在健康细胞中的作用.
- 详细介绍血癌细胞如何劫持线粒体过程.
- 探索针对血液性恶性瘤中线粒体动态的治疗途径.
主要方法:
- 关于癌症中线粒体动态的最新研究的综述.
- 分析使用细胞系,来自患者的样本和异种移植模型的研究.
- 研究线粒体动力学蛋白质的调节机制.
主要成果:
- 血液癌细胞利用线粒体的可塑性进行不受控制的增殖,干性和耐药性.
- 白血病和淋巴瘤细胞适应压力,通过操纵线粒体来逃避治疗.
- 线粒体动力学蛋白在不同的血液性恶性瘤和治疗耐药性中起到特定的作用.
结论:
- 调节线粒体动力学是一种有前途的治疗策略,用于血液恶性瘤.
- 准线粒体动力学调节器可以作为预测生物标志物.
- 需要进行进一步的综合研究,以充分利用血液癌症中线粒体的脆弱性.
相关概念视频
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


